Global COVID-19 EIA/ELISA Medical Devices Pipeline Landscape Report 2021: Product Description, Licensing and Collaboration Details and Other Developmental Activities
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "COVID-19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.
The report provides comprehensive information about the COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
COVID 19 EIA/ELISA are the most widely used assays having high sensitivity and specificity. They are used to detect the recombinant protein and peptide antigens in the samples.
Scope
Extensive coverage of the COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
Overview
3 Products under Development
3.1 Pipeline Products by Stage of Development
3.2 Pipeline Products by Territory
3.3 Pipeline Products by Regulatory Path
3.4 Pipeline Products by Estimated Approval Date
3.5 Ongoing Clinical Trials
4 Pipeline Products under Development by Companies
4.1 Pipeline Products by Stage of Development
5 COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Companies and Product Overview
6 Appendix
Companies Mentioned
20/20 GeneSystems Inc
Abbott Diagnostics
Abbott Laboratories
Absology Co Ltd
Abwiz Bio Inc
Achira Labs Pvt Ltd
ADiTx Therapeutics Inc
ADMA Biologics Inc
AegirBio AB
Aegis Sciences Corp
Affigenix Biosolutions Pvt Ltd
Agilent Technologies Inc
ALPCO Diagnostics
Anhui Deep Blue Medical Technology Co Ltd
Ansh Labs LLC
Arrayit Corp
ARUP Laboratories
Avacta Group Plc
Axim Biotechnologies Inc
Axium BioResearch Inc
Babson Diagnostics Inc
Base10 Genetics Inc
Beckman Coulter Inc
Beijing Shengkun Kangru Medical Equipment Co Ltd
Ben-Gurion University of the Negev
Biohit Healthcare Ltd
BioIQ Inc
Biolinker Synthetic Biology Ltd
Biomerica Inc
Bio-Techne Corp
BioVaxys Technology Corp
Bloom Diagnostics AG
Boston University
BreviTest Technologies LLC
Calviri Inc
Capricor Therapeutics Inc
CareHealth America Corp
Cellex Inc
Cellmid Ltd
Celltrion Inc
Core Technology Co Ltd
DiaCarta Inc
Diagnostics Biochem Canada Inc
DIALAB GmbH
DiaSorin SpA
Diazyme Laboratories Inc
DLS Research and Ventures
DRG International Inc
EDP Biotech Corporation
Empower Clinics Inc
Enable Biosciences Inc
Enzo Biochem Inc
Epigentek Group Inc
Epitope Diagnostics, Inc.
Eurobio Scientific SA
Eurofins Scientific SE
Euroimmun AG
Excelsior Bio-Systems Inc
Ezra AI Inc
Fujirebio Diagnostics Inc
General Biologicals Corp
Halberd Corp
Hecin Scientific Inc
Hunan Lituo Biotechnology Co Ltd
Icosagen AS
ICT International
IDvet
Immunodiagnostics Ltd
ImmunoPrecise Antibodies Ltd
Indian Institute of Technology Guwahati
Interpace Biosciences Inc
Kantaro Biosciences LLC
Kephera Diagnostics LLC
KRISHGEN BioSystems
Lansion Biotechnology Co Ltd
Leadgene Biomedical Inc
Leinco Technologies Inc
Liquid Diagnostics LLC
Lumos Diagnostics Inc
Maxim Biomedical Inc
Meridian Bioscience Inc
Module Innovations Pvt Ltd
Mologic Ltd
Monarch Global Health LLC
Monopar Therapeutics Inc
Nanjing Liming Bio-Products Co Ltd
NanoRepro AG
Nirmidas Biotech Inc
Northwestern University
Novacyt SA
NovaTec Immundiagnostica GmbH
Novo Nordisk AS
OraSure Technologies Inc
Ortho Clinical Diagnostics Holdings Plc
Oy Medix Biochemica Ab
P3 Diagnostics LLC
Pepex Biomedical, Inc.
PerkinElmer Inc
Pinnacle BioLabs
Prantae Solutions Pvt Ltd
Premier Medical Corporation
ProAxsis Ltd
ProGnosis Biotech SA
Promega Corp
ProMIS Neurosciences Inc
Qiagen NV
Qlife Holding AB
Quanterix Corp
Quotient Ltd
Randox Laboratories Ltd
Roche Diagnostics International Ltd
Safetest Comercio de Diagnosticos Ltd
Salofa Oy
ScheBo Biotech AG
Sciteck Diagnostics Inc
Shenzhen Kingfocus Biomedical Engineering Co Ltd
Shenzhen Tisenc Medical Devices Co Ltd
Shijiazhuang Hipro Biotechnology Co Ltd
Siemens Healthcare Diagnostics Inc
Siemens Healthineers AG
SQI Diagnostics Inc
St Petersburg Research Institute of Vaccines and Serums
Stream Bio Ltd
Syngene
Sysmex Corp
Taizhou ZECEN Biotech Co Ltd
The Binding Site Inc
ThermoGenesis Holdings Inc
Trinity College Dublin
University of Melbourne
VidaCheck LLC
VirIntel LLC
Vivera Pharmaceuticals Inc
Vyriad Inc
West Virginia University School of Medicine
Zalgen Labs LLC
Zandcell AB
ZRT Laboratory LLC
For more information about this report visit https://www.researchandmarkets.com/r/msqio7
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900